Eikonizo Therapeutics logo

Eikonizo Therapeutics jobs and careers

Cambridge, MA, United States

About Eikonizo Therapeutics

Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Their first program is focused on a disease-modifying therapeutics for neurodegenerative diseases.

Founded in 2017 by Frederick Schroeder, Jacob Hooker, Janice Kranz and William (Bill) Shaw.

Founded
2017
Employees
11 to 50
Total funding
$2M
Headquarters
Cambridge

Leadership

The top of Eikonizo Therapeutics's org chart, with how many people report into each leader.

JKPhoto of Janice Kranz

Janice Kranz

CEO & Co-Founder

7 reports

ASPhoto of Al Schroeder

Al Schroeder

Co-Founder & Director of R&D

4 reports

JL

Jim Luterman

EVP, Development

FS

Frederick 'Al' Schroeder

Co-Founder and Director of R&D

JG

Jon Graves

VP Finance and Controller

Board

KKPhoto of Kevin Kinsella

Kevin Kinsella

Director

SS

Stuart L. Schreiber

Advisor

BRPhoto of Brad Rosenblum

Brad Rosenblum

Advisor

SWPhoto of Stacie Weninger

Stacie Weninger

Director

LP

Leonard Petrucelli

Advisor

TCPhoto of Todd Cohen

Todd Cohen

Advisor